These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25916503)

  • 1. Long-term persistence of immunity induced by OVA-coupled gas-filled microbubble vaccination partially protects mice against infection by OVA-expressing Listeria.
    Bioley G; Lassus A; Terrettaz J; Tranquart F; Corthésy B
    Biomaterials; 2015 Jul; 57():153-60. PubMed ID: 25916503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vaccines based on ovalbumin coupled to gas-filled microbubbles for reducing infection by ovalbumin-expressing Listeria monocytogenes.
    Bioley G; Zehn D; Lassus A; Terrettaz J; Tranquart F; Corthésy B
    Biomaterials; 2013 Jul; 34(21):5423-30. PubMed ID: 23618628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses.
    Bioley G; Lassus A; Bussat P; Terrettaz J; Tranquart F; Corthésy B
    Biomaterials; 2012 Sep; 33(25):5935-46. PubMed ID: 22652023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
    Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
    J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
    Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
    Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection.
    Cardoso SA; Oliveira AF; Ruas LP; Trevisani MM; De Oliveira LL; Hanna ES; Roque-Barreira MC; Soares SG
    Vaccine; 2013 Sep; 31(41):4528-35. PubMed ID: 23933366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
    Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
    Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
    Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
    Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
    Mosaheb M; Wetzler LM
    Vaccine; 2018 Nov; 36(50):7689-7699. PubMed ID: 30381152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
    Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
    Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single immunization near birth elicits immediate and lifelong protective immunity.
    Reikie BA; Smolen KK; Fortuno ES; Loeffler DI; Cai B; Blimkie D; Kollmann TR
    Vaccine; 2010 Dec; 29(1):83-90. PubMed ID: 21034825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms.
    Loeffler DI; Smolen K; Aplin L; Cai B; Kollmann TR
    Vaccine; 2009 Feb; 27(6):919-27. PubMed ID: 19059297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison Between Recombinant
    Teran-Navarro H; Salcines-Cuevas D; Calderon-Gonzalez R; Tobes R; Calvo-Montes J; Pérez-Del Molino Bernal IC; Yañez-Diaz S; Fresno M; Alvarez-Dominguez C
    Front Immunol; 2021; 12():632304. PubMed ID: 33953709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice.
    Kweon MN; Fujihashi K; VanCott JL; Higuchi K; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1998 Feb; 160(4):1687-93. PubMed ID: 9469425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.
    Bohnen C; Wangorsch A; Schülke S; Nakajima-Adachi H; Hachimura S; Burggraf M; Süzer Y; Schwantes A; Sutter G; Waibler Z; Reese G; Toda M; Scheurer S; Vieths S
    Allergy; 2013 Aug; 68(8):1021-8. PubMed ID: 23909913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.